Testing B-OK Bottles for HIV Medication Understanding in South Africa
Part of Infections clinical trials.
This study tests a special 'B-OK' bottle designed to help people understand their HIV medication better. If you live in Gauteng and can come to the study offices for one visit, you might help find better ways to support HIV treatment with simple tools.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You live in Gauteng province, South Africa.
- You can understand and speak English or another language used in the study.
- You are willing to come in person to the HE2RO research offices for a visit.
- You can provide your contact details so the study team can reach you in six weeks.
- You can give written permission (informed consent) to be in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a long-acting injectable HIV medicine (given every couple of months) and teen support clubs can help adolescents stay healthy and engaged in care. If you are a teen living with HIV, this trial may offer a more convenient treatment option.
This trial tests if structured home care and nutritional support can help people with HIV recover and stay healthy after leaving the hospital. If you live in the Matlosana area and were recently admitted to Tshepong Hospital, you may be able to join.
This trial is testing whether a program that teaches about 'U=U' (Undetectable = Untransmittable) can improve HIV counseling in South African public clinics. You may be eligible if you are an adult receiving HIV counseling at a participating clinic and speak one of the study languages.
This study tests a program that helps people with HIV manage depression and stick to their treatment. It's for adults in Cape Town, South Africa, who have a detectable HIV viral load or may have one, and who show signs of depression.
This study is testing three experimental antibodies (ePGT121v1-LS, PGDM1400LS, and VRC07-523LS) that may help prevent HIV. It’s looking at their safety and how long they stay in the body. Healthy volunteers without HIV can join.
This research study collects blood cells from people recently diagnosed with HIV who haven't started HIV medicines yet. Researchers use these samples to understand how HIV affects the immune system and develop better treatments.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.